Peptide Therapy in the UAE: A 2026 Patient Guide

Peptide therapy went from a niche interest to a mainstream conversation in the UAE faster than the information around it improved. Most of what you can read is still written by people selling vials, which means it is all about which vial to pick and almost never about whether you should be taking one.

This guide is the other version. What these compounds are, how you tell verified material from a label, what the UAE regulatory position actually is, and what happens in a proper clinical assessment.

Almost everyone arrives here with a symptom rather than a compound, weight that will not shift, recovery that has stalled, energy that is gone, sleep that is not working. Those are real, and they are also non-specific. Thyroid dysfunction, iron deficiency, sleep apnoea, medication side effects and simple under-recovery all produce the same list, and all of them have better answers than a peptide.

This is the single strongest argument for starting with an assessment rather than a product page. Not because peptides never help, but because roughly the first thing a good assessment does is rule out the boring explanations. A seller has no mechanism for that and no incentive to look.

If something is going into you, two tests decide whether it is what the label claims.

Purity comes from high performance liquid chromatography (HPLC), which separates everything in the sample and reports each fraction as a percentage. A genuine result is a number, not an adjective. Identity comes from mass spectrometry (MS), which weighs the molecule and confirms it matches the expected mass. Purity without identity means clean but unidentified; identity without purity means present but possibly diluted. You want both, on the specific batch.

A Certificate of Analysis should carry a batch or lot number matching your vial, an HPLC percentage, a mass-spec result, a test date, and the name of an independent testing lab. Janoshik Analytical is the one you will see most, because its reports can be checked through its own portal. Ask to see the report for your batch before you start.

Peptides are supplied lyophilised because freeze-dried is the most stable state they have. Ambient temperatures here still beat that. A compound that spent two days in a warm vehicle can arrive with flawless documentation and very little activity left, and you cannot tell by looking. Where the cold chain is nobody's explicit responsibility, it is not happening.

Most peptide compounds are not registered medicines in the UAE. They are generally not scheduled as controlled substances either, but that is a narrower statement than it sounds, not being a scheduled narcotic is not the same as being approved or lawful to supply as a treatment.

Importing regulated-medicine material for personal use generally requires a MOHAP permit, and shipments are subject to customs inspection, holds and refusal. This is not a jurisdiction in which to be casual about that. Our guide to the UAE regulations covers it properly. The clean route is the deliberate one: you are assessed first, the material is documented, and somebody is accountable for what happens next.

• Any seller giving you a human dose without a clinician having assessed you.
• No Certificate of Analysis, or "lab tested" with nothing readable behind it.
• A CoA with no batch number, no date, or no named lab.
• Investigational compounds, retatrutide among them, described as approved or proven.
• A price far below everyone else with no explanation.
• A process with no possible outcome except a sale.

Each has a clinical reference covering what it is, what the evidence supports, and who it suits:

• Retatrutide, GLP-1 / GIP / glucagon triple agonist. Investigational, still in Phase 3.
• Tesamorelin, stabilised GHRH analogue, studied in visceral fat and IGF-1 work.
• BPC-157 / TB-500, dual tissue-repair pairing acting on complementary pathways.
• GHK-Cu, copper peptide, studied in wound healing, collagen and skin biology.
• MOTS-c, mitochondrial-derived peptide, metabolic regulation and insulin sensitivity.
• NAD+, cellular energy metabolism and longevity pathways.
• CJC-1295 / Ipamorelin, GHRH analogue paired with a selective secretagogue.

Baseline is a consultation-led service, not a shop. You complete a short assessment, your consultant reads your history and medications, and you have a consultation covering what you are actually trying to solve, whether something more common explains it, baseline bloods where needed, and whether treatment is appropriate at all. If it is, it is set out, dosed and monitored. If it is not, you are told so.

See who you will be speaking to, or book the consultation.

This article is educational and is not legal advice, medical advice, a diagnosis, or a treatment plan. A consultation decides what is appropriate for you.